Skip to main content

Advertisement

SpringerLink
Log in

Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background

Preclinical and clinical evidence support an association between vitamin D deficiency and an increased risk of colorectal cancer. Normal vitamin D status has been linked to favorable health outcomes ranging from decreased risk of osteoporosis to improved cancer mortality. We performed a retrospective study to assess the impact of metastatic disease and chemotherapy treatment on vitamin D status in patients with colorectal cancer residing in Western New York.

Materials and methods

Patients, 315, with colorectal cancer treated in a single institute were assayed for 25-OH vitamin D. The association of age, gender, primary disease site and stage, body mass index, and chemotherapy with vitamin D status was investigated.

Results

Vitamin D deficiency was common among participants with a median 25-OH vitamin D level of 21.3 ng/ml (optimal range 32–100 ng/ml). Primary site of disease and chemotherapy status were associated with very low 25-OH vitamin D levels (≤15 ng/ml) on multivariate analysis. Patients receiving chemotherapy and patients with a rectal primary were 3.7 and 2.6-fold more likely to have severe vitamin D deficiency on multivariate analysis than nonchemotherapy patients and colon cancer primary patients, respectively.

Conclusions

Chemotherapy is associated with a significant increase in the risk of severe vitamin D deficiency. Patients with colorectal cancer, especially those receiving chemotherapy, should be considered for aggressive vitamin D replacement strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Notes

  1. http://www.labcorp.com/datasets/labcorp/html/chapter/mono/sr004600.htm, last accessed on January 05, 2008

References

  1. Garland CF, Garland FC (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9(3):227–231

    Article  PubMed  CAS  Google Scholar 

  2. Holick M (2007) Vitamin D Deficiency. NEJM 357:266–281

    Article  PubMed  CAS  Google Scholar 

  3. Garland CF et al (1989) Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2(8673):1176–1178

    Article  PubMed  CAS  Google Scholar 

  4. Tangrea J et al (1997) Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8(4):615–625

    Article  PubMed  CAS  Google Scholar 

  5. Feskanich D et al (2004) Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13(9):1502–1508

    PubMed  CAS  Google Scholar 

  6. Wactawski-Wende J et al (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354(7):684–696

    Article  PubMed  CAS  Google Scholar 

  7. Wu K et al (2007) A nested case-control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 99(14):1120–1129

    Article  PubMed  CAS  Google Scholar 

  8. Niv Y et al (1999) In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma. Cancer 86(3):391–397

    Article  PubMed  CAS  Google Scholar 

  9. Levine AJ et al (2001) Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer 39(1):35–41

    Article  PubMed  CAS  Google Scholar 

  10. Grau MV et al (2003) Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95(23):1765–1771

    PubMed  CAS  Google Scholar 

  11. Zhou W et al (2007) Circulating 25-hydroxyvitamin d levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 25(5):479–485

    Article  PubMed  CAS  Google Scholar 

  12. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135(2):317–322

    PubMed  CAS  Google Scholar 

  13. Thomas MG et al (1999) Vitamin D receptor expression in colorectal cancer. J Clin Pathol 52(3):181–183

    Article  PubMed  CAS  Google Scholar 

  14. Meggouh F et al (1990) Evidence of 1,25-dihydroxyvitamin D3-receptors in human digestive mucosa and carcinoma tissue biopsies taken at different levels of the digestive tract, in 152 patients. J Steroid Biochem 36(1–2):143–147

    Article  PubMed  CAS  Google Scholar 

  15. Cross HS et al (1996) Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res 16(4B):2333–2337

    PubMed  CAS  Google Scholar 

  16. Evans SR et al (1998) Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer. Clin Cancer Res 4(7):1591–1595

    PubMed  CAS  Google Scholar 

  17. Matusiak D et al (2005) Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon. Cancer Epidemiol Biomarkers Prev 14(10):2370–2376

    Article  PubMed  CAS  Google Scholar 

  18. Kallay E et al (2001) Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22(9):1429–1435

    Article  PubMed  CAS  Google Scholar 

  19. Kallay E et al (2002) Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem Toxicol 40(8):1191–1196

    Article  PubMed  CAS  Google Scholar 

  20. Holt PR et al (2006) Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa. Cancer 106(2):287–296

    Article  PubMed  CAS  Google Scholar 

  21. Holt PR et al (2002) Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev 11(1):113–119

    PubMed  CAS  Google Scholar 

  22. Miller EA et al (2007) Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas. Cancer 109(3):510–517

    Article  PubMed  CAS  Google Scholar 

  23. Peters U et al (2001) Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 10(12):1267–1274

    PubMed  CAS  Google Scholar 

  24. Gorham ED et al (2007) Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 32(3):210–216

    Article  PubMed  Google Scholar 

  25. Braun MM et al (1995) Colon cancer and serum vitamin D metabolite levels 10–17 years prior to diagnosis. Am J Epidemiol 142(6):608–611

    PubMed  CAS  Google Scholar 

  26. Ng K et al (2008) Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 26(18):2984–2991

    Article  PubMed  CAS  Google Scholar 

  27. Boscoe FP, Schymura MJ (2006) Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002. BMC Cancer 6:264

    Article  PubMed  CAS  Google Scholar 

  28. Otani T et al (2007) Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. Br J Cancer 97(3):446–451

    Article  PubMed  CAS  Google Scholar 

  29. Sinicrope FA et al (2006) Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers. Am J Gastroenterol 101(12):2818–2825

    Article  PubMed  CAS  Google Scholar 

  30. Camps J et al (2006) Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis 27(3):419–428

    Article  PubMed  CAS  Google Scholar 

  31. Edmonston TB et al (2000) Colorectal carcinomas with high microsatellite instability: defining a distinct immunologic and molecular entity with respect to prognostic markers. Hum Pathol 31(12):1506–1514

    Article  PubMed  CAS  Google Scholar 

  32. Adams JS et al (2007) Vitamin D in defense of the human immune response. Ann N Y Acad Sci 1117:94–105

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study was partly supported by a Mentored Scholar Award Grant by the American Cancer Society to MGF.

There are no financial conflicts to report.

Author information

Authors and Affiliations

  1. Department of Medicine, Roswell Park Cancer Institute and the University at Buffalo, Buffalo, NY, 14263, USA

    Marwan G. Fakih, Donald L. Trump & Josephia Muindi

  2. Department of Pharmacology, Roswell Park Cancer Institute, Buffalo, NY, 14263, USA

    Candace S. Johnson

  3. Department of Biostatistics, Roswell Park Cancer Institute and the University at Buffalo, Buffalo, NY, 14263, USA

    Lili Tian

  4. Cancer Prevention and Population Science, Roswell Park Cancer Institute, Buffalo, NY, 14263, USA

    Annette Y. Sunga

  5. Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton, Buffalo, NY, 14263, USA

    Marwan G. Fakih

Authors
  1. Marwan G. Fakih
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Donald L. Trump
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Candace S. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lili Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Josephia Muindi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Annette Y. Sunga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marwan G. Fakih.

Additional information

This manuscript was presented in part at GI ASCO 2007.

All authors have read and approved the manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fakih, M.G., Trump, D.L., Johnson, C.S. et al. Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis 24, 219–224 (2009). https://doi.org/10.1007/s00384-008-0593-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-008-0593-y

Keywords

Search

Navigation